These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33863907)

  • 1. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1.
    Vuorela A; Freitag TL; Leskinen K; Pessa H; Härkönen T; Stracenski I; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Ilonen J; Knip M; Vaheri A; Partinen M; Saavalainen P; Meri S; Vaarala O
    Nat Commun; 2021 Apr; 12(1):2283. PubMed ID: 33863907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
    Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
    PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in Pandemrix
    Wallenius M; Lind A; Akel O; Karlsson E; Svensson M; Arvidsson E; Ramelius A; Törn C; Palm L; Lernmark Å; Elding Larsson H
    Autoimmunity; 2019 Jun; 52(4):185-191. PubMed ID: 31328572
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell reactivity to regulatory factor X4 in type 1 narcolepsy.
    Luo G; Yogeshwar S; Lin L; Mignot EJ
    Sci Rep; 2021 Apr; 11(1):7841. PubMed ID: 33837283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling.
    Sadam H; Pihlak A; Kivil A; Pihelgas S; Jaago M; Adler P; Vilo J; Vapalahti O; Neuman T; Lindholm D; Partinen M; Vaheri A; Palm K
    EBioMedicine; 2018 Mar; 29():47-59. PubMed ID: 29449194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy.
    De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E
    Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.
    Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlström L; Bergman P; Granath F; Adori C; Hökfelt T; Kühlmann-Berenzon S; Liljeström P; Maeurer M; Olsson T; Örtqvist Å; Partinen M; Salmonson T; Zethelius B
    J Intern Med; 2015 Oct; 278(4):335-53. PubMed ID: 26123389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.
    Thebault S; Waters P; Snape MD; Cottrell D; Darin N; Hallböök T; Huutoniemi A; Partinen M; Pollard AJ; Vincent A
    PLoS One; 2015; 10(6):e0129555. PubMed ID: 26090827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
    Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I
    PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis.
    Lind A; Marzinotto I; Brigatti C; Ramelius A; Piemonti L; Lampasona V
    Sci Rep; 2021 Feb; 11(1):4063. PubMed ID: 33603024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.
    Ahmed SS; Volkmuth W; Duca J; Corti L; Pallaoro M; Pezzicoli A; Karle A; Rigat F; Rappuoli R; Narasimhan V; Julkunen I; Vuorela A; Vaarala O; Nohynek H; Pasini FL; Montomoli E; Trombetta C; Adams CM; Rothbard J; Steinman L
    Sci Transl Med; 2015 Jul; 7(294):294ra105. PubMed ID: 26136476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy Associated with Pandemrix Vaccine.
    Sarkanen T; Alakuijala A; Julkunen I; Partinen M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(7):43. PubMed ID: 29855798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for autoantibody targets in post-vaccination narcolepsy using proteome arrays.
    Lind A; Eriksson D; Akel O; Ramelius A; Palm L; Lernmark Å; Kämpe O; Elding Larsson H; Landegren N
    Scand J Immunol; 2020 Apr; 91(4):e12864. PubMed ID: 32056243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.
    Luo G; Ambati A; Lin L; Bonvalet M; Partinen M; Ji X; Maecker HT; Mignot EJ
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12323-E12332. PubMed ID: 30541895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.
    Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å
    Viral Immunol; 2017 Oct; 30(8):590-600. PubMed ID: 28796576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy type 1 patients have lower levels of effector memory CD4
    Viste R; Lie BA; Viken MK; Rootwelt T; Knudsen-Heier S; Kornum BR
    Sleep Med; 2021 Sep; 85():271-279. PubMed ID: 34388506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.